Slyper, A H <br/><br/>
A study of chromosomal aberrations and chromosomal fragility after recombinant growth hormone treatment.  [electronic resource] 

 -  Pediatric research  May 2000 
 - 634-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0031-3998 
<br/><br/><label>Standard No.: </label>10.1203/00006450-200005000-00013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Cells, Cultured<br/>Child<br/>Child, Preschool<br/>Chromatids--drug effects<br/>Chromosome Aberrations<br/>Chromosome Fragility<br/>Chromosomes, Human--drug effects<br/>Female<br/>Growth Disorders--blood<br/>Human Growth Hormone--adverse effects<br/>Humans<br/>Lymphocytes--blood<br/>Male<br/>Metaphase--drug effects<br/>Resting Phase, Cell Cycle--radiation effects<br/>Turner Syndrome--blood